ABSTRACT
This groundbreaking AI-driven technology is transforming personalized medicine by enabling the identification of optimal medication candidates, predicting their effectiveness, and creating tailored treatment plans. By integrating molecular simulations, deep learning algorithms, and bioinformatics, the approach significantly reduces the time and cost of traditional drug discovery. Leveraging multi-omics data, including genomics, proteomics, and transcriptomics, it enhances drug design, optimizes molecular interactions, and accelerates drug target identification. Early results from pilot studies indicate improved drug development efficiency and precise predictions of individual patient responses. This AI-based paradigm has the potential to revolutionize precision medicine, offering patients customized therapies and better treatment options for various medical conditions.
